API | bryophyllum

bryophyllum Report issue

Botanical Experimental

AACT

Active Ingredient History

NOW

Bryophyllum is a group of plant species of the family Crassulaceae native to Madagascar. It is a section or subgenus within the genus Kalanchoe, and was formerly placed at the level of genus. This section is notable for vegetatively growing small plantlets on the fringes of the leaves; these eventually drop off and root. These plantlets arise from mitosis of meristematic-type tissue in notches in the leaves. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules: Missing data

More Chemistry

Pharmacology

Mechanism of Action:
Multi-specific: Missing data
Black Box: Missing data
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: Missing data

bryophyllum

Organizations (4)

Research & Development (4)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (10)

Approved Indications (1)

Diabetes Mellitus, Type 2

Experimental Indications - Clinical Trial Phases 1-4 (9)

Anxiety (Phase 2)

Anxiety Disorders (Phase 4)

Cervix Uteri (Phase 4)

Delivery, Obstetric (Phase 4)

Infant, Premature (Phase 4)

Obstetric Labor, Premature (Phase 2)

Tocolysis (Phase 2/Phase 3)

Urinary Bladder, Overactive (Phase 2/Phase 3)

Urinary Incontinence, Urge (Phase 2/Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 7
# of Trial Organizations: 4

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue